Atlas Trials

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Clinical trial NCT02981368 · COMPLETED

Trial details

NCT number
NCT02981368
Sponsor
Progenics Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-11-01
Primary completion
2018-07-01
Enrollment
385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.